MedPath

A randomized controlled trial of enhanced cognitive behavioral therapy (CBT-E) and treatment as usual (TAU) for anorexia nervosa.

Phase 3
Recruiting
Conditions
anorexia nervosa
Registration Number
JPRN-UMIN000048847
Lead Sponsor
The University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
56
Inclusion Criteria

Not provided

Exclusion Criteria

Those who are receiving or have received any type of structured psychotherapies : CBT- E, Family therapy, MANTRA, SSCM, Interpersonal Therapy (IPT). Those who have Axis-I or Axis-II psychiatric disorders : schizophrenia, bipolar disorder, substance use disorder, or somatic disease that impedes the treatment of CBT-E. Those prescribed antipsychotic medication except for antidepressant, anxiolytic or hypnotics. Those with intellectual disability. Those who are at imminent risk of suicide. Those who are pregnant or might become pregnant. Those who have difficulty in attending scheduled therapy sessions. Those who are not considered eligible to participate in the study by research directors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body mass index (kg/m2) at 40 weeks after treatment was initiated.
Secondary Outcome Measures
NameTimeMethod
Japanese version of Eating Disorder Examination-Questionnaire (EDE-Q-J) . Japanese version of Clinical Impairment Assessment questionnaire (CIA)
© Copyright 2025. All Rights Reserved by MedPath